A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The study will evaluate the effect of oral contraceptive (birth control pill) on the blood level of lanabecestat when both are given together. Side effects will be monitored and documented. This study will last up to 27 days for each participant, not including screening. Screening is required within 42 days prior to first dose.
Epistemonikos ID: aea683ae937c322a6dd493df3dc10beee3cc41a6
First added on: May 21, 2024